387 related articles for article (PubMed ID: 31770016)
1. Combined effects of
Shin NR; Gu N; Choi HS; Kim H
Am J Physiol Endocrinol Metab; 2020 Jan; 318(1):E52-E61. PubMed ID: 31770016
[TBL] [Abstract][Full Text] [Related]
2. Effects of Initial Combinations of Gemigliptin Plus Metformin Compared with Glimepiride Plus Metformin on Gut Microbiota and Glucose Regulation in Obese Patients with Type 2 Diabetes: The INTESTINE Study.
Lim S; Sohn M; Florez JC; Nauck MA; Ahn J
Nutrients; 2023 Jan; 15(1):. PubMed ID: 36615904
[TBL] [Abstract][Full Text] [Related]
3. Effects of combination treatment with metformin and berberine on hypoglycemic activity and gut microbiota modulation in db/db mice.
Lyu Y; Li D; Yuan X; Li Z; Zhang J; Ming X; Shaw PC; Zhang C; Kong APS; Zuo Z
Phytomedicine; 2022 Jul; 101():154099. PubMed ID: 35489323
[TBL] [Abstract][Full Text] [Related]
4. Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading Akkermansia muciniphila and Several Short-Chain Fatty Acid-Producing Microbiota in the Gut.
de la Cuesta-Zuluaga J; Mueller NT; Corrales-Agudelo V; Velásquez-Mejía EP; Carmona JA; Abad JM; Escobar JS
Diabetes Care; 2017 Jan; 40(1):54-62. PubMed ID: 27999002
[TBL] [Abstract][Full Text] [Related]
5. Combination of
Ansari A; Bose S; Lim SK; Wang JH; Choi YH; Kim H
Am J Chin Med; 2020; 48(6):1409-1433. PubMed ID: 32907360
[No Abstract] [Full Text] [Related]
6. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study.
Bryrup T; Thomsen CW; Kern T; Allin KH; Brandslund I; Jørgensen NR; Vestergaard H; Hansen T; Hansen TH; Pedersen O; Nielsen T
Diabetologia; 2019 Jun; 62(6):1024-1035. PubMed ID: 30904939
[TBL] [Abstract][Full Text] [Related]
7. Metformin alters the gut microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug.
Wu H; Esteve E; Tremaroli V; Khan MT; Caesar R; Mannerås-Holm L; Ståhlman M; Olsson LM; Serino M; Planas-Fèlix M; Xifra G; Mercader JM; Torrents D; Burcelin R; Ricart W; Perkins R; Fernàndez-Real JM; Bäckhed F
Nat Med; 2017 Jul; 23(7):850-858. PubMed ID: 28530702
[TBL] [Abstract][Full Text] [Related]
8. Metformin Reduces Blood Glucose in Treatment-Naive Type 2 Diabetes by Altering the Gut Microbiome.
He D; Han H; Fu X; Liu A; Zhan Y; Qiu H; Ma L; Zhang X; Wang X
Can J Diabetes; 2022 Mar; 46(2):150-156. PubMed ID: 35148952
[TBL] [Abstract][Full Text] [Related]
9. Peanut skin extract ameliorates the symptoms of type 2 diabetes mellitus in mice by alleviating inflammation and maintaining gut microbiota homeostasis.
Xiang L; Wu Q; Osada H; Yoshida M; Pan W; Qi J
Aging (Albany NY); 2020 Jul; 12(14):13991-14018. PubMed ID: 32699185
[TBL] [Abstract][Full Text] [Related]
10. In vivo therapeutic effect of combination treatment with metformin and Scutellaria baicalensis on maintaining bile acid homeostasis.
Han K; Bose S; Wang JH; Lim SK; Chin YW; Kim YM; Choi HS; Kim H
PLoS One; 2017; 12(9):e0182467. PubMed ID: 28877164
[TBL] [Abstract][Full Text] [Related]
11. Different effects of basal insulin peglispro and insulin glargine on liver enzymes and liver fat content in patients with type 1 and type 2 diabetes.
Cusi K; Sanyal AJ; Zhang S; Hoogwerf BJ; Chang AM; Jacober SJ; Bue-Valleskey JM; Higdon AN; Bastyr EJ; Haupt A; Hartman ML
Diabetes Obes Metab; 2016 Oct; 18 Suppl 2():50-58. PubMed ID: 27723227
[TBL] [Abstract][Full Text] [Related]
12. Effects of metformin, saxagliptin and repaglinide on gut microbiota in high-fat diet/streptozocin-induced type 2 diabetic mice.
Tang Y; Yan M; Fang Z; Jin S; Xu T
BMJ Open Diabetes Res Care; 2024 May; 12(3):. PubMed ID: 38719505
[TBL] [Abstract][Full Text] [Related]
13. Scutellaria baicalensis enhances the anti-diabetic activity of metformin in streptozotocin-induced diabetic Wistar rats.
Waisundara VY; Hsu A; Huang D; Tan BK
Am J Chin Med; 2008; 36(3):517-40. PubMed ID: 18543386
[TBL] [Abstract][Full Text] [Related]
14. The effects of metformin on glycemic control and serum lipids in insulin-treated NIDDM patients with suboptimal metabolic control.
Robinson AC; Burke J; Robinson S; Johnston DG; Elkeles RS
Diabetes Care; 1998 May; 21(5):701-5. PubMed ID: 9589227
[TBL] [Abstract][Full Text] [Related]
15. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota.
Forslund K; Hildebrand F; Nielsen T; Falony G; Le Chatelier E; Sunagawa S; Prifti E; Vieira-Silva S; Gudmundsdottir V; Pedersen HK; Arumugam M; Kristiansen K; Voigt AY; Vestergaard H; Hercog R; Costea PI; Kultima JR; Li J; Jørgensen T; Levenez F; Dore J; ; Nielsen HB; Brunak S; Raes J; Hansen T; Wang J; Ehrlich SD; Bork P; Pedersen O
Nature; 2015 Dec; 528(7581):262-266. PubMed ID: 26633628
[TBL] [Abstract][Full Text] [Related]
16. Host-microbiome interactions in human type 2 diabetes following prebiotic fibre (galacto-oligosaccharide) intake.
Pedersen C; Gallagher E; Horton F; Ellis RJ; Ijaz UZ; Wu H; Jaiyeola E; Diribe O; Duparc T; Cani PD; Gibson GR; Hinton P; Wright J; La Ragione R; Robertson MD
Br J Nutr; 2016 Dec; 116(11):1869-1877. PubMed ID: 27974055
[TBL] [Abstract][Full Text] [Related]
17. Response of gut microbiota in type 2 diabetes to hypoglycemic agents.
Zhang F; Wang M; Yang J; Xu Q; Liang C; Chen B; Zhang J; Yang Y; Wang H; Shang Y; Wang Y; Mu X; Zhu D; Zhang C; Yao M; Zhang L
Endocrine; 2019 Dec; 66(3):485-493. PubMed ID: 31410749
[TBL] [Abstract][Full Text] [Related]
18. Effects of multiple ascending doses of the glucagon receptor antagonist PF-06291874 in patients with type 2 diabetes mellitus.
Kazierad DJ; Bergman A; Tan B; Erion DM; Somayaji V; Lee DS; Rolph T
Diabetes Obes Metab; 2016 Aug; 18(8):795-802. PubMed ID: 27059951
[TBL] [Abstract][Full Text] [Related]
19. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice.
Shin NR; Lee JC; Lee HY; Kim MS; Whon TW; Lee MS; Bae JW
Gut; 2014 May; 63(5):727-35. PubMed ID: 23804561
[TBL] [Abstract][Full Text] [Related]
20. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]